Biological disposition of apomorphine. II. Urinary excretion and organ distribution of apomorphine

P N KAUL et al. J Pharm Sci. 1961 Mar.

. 1961 Mar:50:244-7.

doi: 10.1002/jps.2600500316.

No abstract available

Similar articles

Biological disposition of apomorphine. III. Kinetics of metabolism of apomorphine and role of the liver in its biotransformation.
KAUL PN, BROCHMANN-HANSSEN E, WAY EL. KAUL PN, et al. J Pharm Sci. 1961 Mar;50:248-51. doi: 10.1002/jps.2600500317. J Pharm Sci. 1961. PMID: 13751908 No abstract available.
Some observations on pecking in pigeons.
DESHPANDE VR, SHARMA ML, KHERDIKAR PR, GREWAL RS. DESHPANDE VR, et al. Br J Pharmacol Chemother. 1961 Aug;17(1):7-11. doi: 10.1111/j.1476-5381.1961.tb01098.x. Br J Pharmacol Chemother. 1961. PMID: 13722178 Free PMC article.
Biological disposition of apomorphine. IV. Isolation and characterization of "bound" apomorphine.
KAUL PN, BROCHMANN-HANSSEN E, WAY EL. KAUL PN, et al. J Pharm Sci. 1961 Oct;50:840-2. doi: 10.1002/jps.2600501008. J Pharm Sci. 1961. PMID: 14454485 No abstract available.
Subcutaneously administered apomorphine: pharmacokinetics and metabolism.
LeWitt PA. LeWitt PA. Neurology. 2004 Mar 23;62(6 Suppl 4):S8-11. doi: 10.1212/wnl.62.6_suppl_4.s8. Neurology. 2004. PMID: 15037665 Review.
Pharmacokinetics of apomorphine in Parkinson's disease.
Gancher S. Gancher S. J Neural Transm Suppl. 1995;45:137-41. J Neural Transm Suppl. 1995. PMID: 8748619 Review.

Age difference in apomorphine-induced stereotypy in rats: relationship to plasma and brain concentrations.
Watanabe H, Nakano S, Ogawa N. Watanabe H, et al. Psychopharmacology (Berl). 1982;76(1):57-61. doi: 10.1007/BF00430756. Psychopharmacology (Berl). 1982. PMID: 6805010
Pharmacokinetic-pharmacodynamic relationships of apomorphine in patients with Parkinson's disease.
Neef C, van Laar T. Neef C, et al. Clin Pharmacokinet. 1999 Sep;37(3):257-71. doi: 10.2165/00003088-199937030-00004. Clin Pharmacokinet. 1999. PMID: 10511920 Review.